BASi (Bioanalytical Systems Inc.) is expanding its drug discovery and development services capabilities. The company has renovated space at its preclinical toxicology site in Evansville, IN and will relocate some research services to West Lafayette, IN, creating several new positions. BASi also has added research instrumentation at its bioanalytical labs at three sites. The company is using proceeds from a $5.5 million public offering to make the improvements and purchase lab equipment. The bui...